Radiopharmaceuticals for clinical cardiac PET imaging

Cardiac PET and PET/CT Imaging

Volumn , Issue , 2007, Pages 73-82

  Machac, Josef ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84886202857     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-38295-1_5     Document Type: Chapter

References (27)

1. Gould KL, Schelbert HR, Phelps ME, Hoffman EJ. Noninvasive assessment of coronary stenoses with myocardial perfusion imaging during pharmacologic coronary vasodilatation. V. Detection of 47 percent diameter coronary stenosis with intravenous nitrogen-13 ammonia and emission-computed tomography in intact dogs. Am J Cardiol. 1979;43:200-208.
2. Schelbert HR, Wisenberg G, Phelps ME, et al. Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation. VI. Detection of coronary artery disease in human beings with intravenous N-13 ammonia and positron computed tomography. Am J Cardiol. 1982;49:1197-1207.
3. Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med. 1986;314:884-888.
4. Vaalburg W, Kamphuis JA, Beerling-Van der Molen HD, Rijskamp A, Woldring MG. An improved method for the cyclotron production of 13N-labelled ammonia. Int J Appl Radiat Isot. 1975;26:316-318.
5. Wieland B, Bida G, Padgett H, et al. In-target production of [13N]ammonia via proton irradiation of dilute aqueous ethanol and acetic acid mixtures. Int J Rad Appl Instrum [A]. 1991;42:1095-1098.
6. Schelbert HR, Phelps ME, Hoffman EJ, Huang SC, Selin CE, Kuhl DE. Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomography. Am J Cardiol. 1979;43:209-218.
7. Schelbert HR, Phelps ME, Huang SC, et al. N-13 ammonia as an indicator of myocardial blood flow. Circulation. 1981;63:1259-1272.
8. Schelbert HR, Schwaiger M. PET studies of the heart. In: Phelps ME, Mazziotta JC, Schelbert HR, eds. Positron Emission Tomography and Autoradiography, Principles and Applications for the Brain and Heart. New York: Raven Press; 1986:581-661.
9. Beanlands RS, Muzik O, Hutchins GD, Wolfe ER Jr, Schwaiger M. Heterogeneity of regional nitrogen 13-labeled ammonia tracer distribution in the normal human heart: comparison with rubidium 82 and copper 62-labeled PTSM. J Nucl Cardiol. 1994;1:225-235.
10. Yoshida K, Mullani N, Gould KL. Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia. J Nucl Med. 1996;37:1701-1712.
11. Tamaki N, Ruddy TD, Dekamp R. Myocardial perfusion. In: Wahl RL, Buchanan JW, eds. Principles and Practice of Positron Emission Tomography. Philadelphia, PA: Lippincott Williams & Wilkins; 2002:320-333.
12. Hickey KT, Sciacca RR, Bokhari S, et al. Assessment of cardiac wall motion and ejection fraction with gated PET using N-13 ammonia. Clin Nucl Med. 2004;29:243-248.
13. Thomas KE. Strontium 82 production at Los Alamos National Laboratory. Int J Appl Radiat Isot. 1987;38:175-180.
14. Kim SH, Machac J, Almeida O. Optimization of rubidium-82 generator performance. Clin Nucl Med. 2004;29:135.
15. Chow BJ, Ananthasubramaniam K, Dekemp RA, Dalipaj MM, Beanlands RS, Ruddy TD. Comparison of treadmill exercise versus dipyridamole stress with myocardial perfusion imaging using rubidium-82 positron emission tomography. J Am Coll Cardiol. 2005;45:1227-1234.
16. Meerdink DJ, Leppo JA. Experimental studies of the physiologic properties of technetium-99m agents: myocardial transport of perfusion imaging agents. Am J Cardiol. 1990;66:9E-15E.
17. Leppo JA, Meerdink DJ. Comparison of the myocardial uptake of a technetium-labeled isonitrile analogue and thallium. Circ Res. 1989;65:632-639.
18. Mack RE, Nolting DD, Hogancamp CE, Bing RJ. Myocardial extraction of Rb-86 in the rabbit. Am J Physiol. 1959;197:1175-1177.
19. Becker L, Ferreira R, Thomas M. Comparison of 86Rb and microsphere estimates of left ventricular bloodflow distribution. J Nucl Med. 1974;15:969-973.
20. Selwyn AP, Allan RM, L'Abbate A, et al. Relation between regional myocardial uptake of rubidium-82 and perfusion: absolute reduction of cation uptake in ischemia. Am J Cardiol. 1982;50:112-121.
21. Schelbert HR, Ashburn WL, Chauncey DM, Halpern SE. Comparative myocardial uptake of intravenously administered radionuclides. J Nucl Med. 1974;15:1092-1100.
22. Goldstein RA, Mullani NA, Marani SK, Fisher DJ, Gould KL, O'Brien HA Jr. Myocardial perfusion with rubidium-82. II. Effects of metabolic and pharmacologic interventions. J Nucl Med. 1983;24:907-915.
23. Schelbert HR. Evaluation of myocardial blood flow in cardiac disease. In: Skorton DJ, Schelbert HR, Wolf GL, Brundage BH, eds. Cardiac Imaging. A Companion to Braunwald's Heart Disease. Philadelphia: WB Saunders; 1991:1093-1112.
24. Mullani NA, Goldstein RA, Gould KL, et al. Myocardial perfusion with rubidium-82. I. Measurement of extraction fraction and flow with external detectors. J Nucl Med. 1983;24:898-906.
25. Hamacher K, Coenen HH, Stocklin G. Efficient stereospecific synthesis of no-carrieradded 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med. 1986;27:235-238.
26. Gallagher BM, Ansari A, Atkins H, et al. Radiopharmaceuticals XXVII. 18F-labeled 2-deoxy-2-fluoro-d-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distribution and imaging studies in animals. J Nucl Med. 1977;18:990-996.
27. Ratib O, Phelps ME, Huang SC, Henze E, Selin CE, Schelbert HR. Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nucl Med. 1982;23:577-586.